YMAB: Nilai perusahaan marang bathi resik Y-mAbs Therapeutics Inc

Y-mAbs Therapeutics Inc - logo grafis emiten YMAB

Y-mAbs Therapeutics (YMAB) is implementing artificial intelligence for molecule design by leveraging the automated capacities of its partners. The company attracts leading antibody specialists through an RSU system and an ethical approach to work. The market valuation trend at -18.10 confirms the growth potential of DANYELZA and a productive R&D pipeline in the field of precision therapy for pediatric tumors.

Koefisien rega marang bathi: Y-mAbs Therapeutics (YMAB) kanggo 04.07.2022 - 27.09.2025

Rincian metrik komprehensif lan analitis YmAbs (YMAB)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega ymabs.com|YMAB - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Y-mAbs Therapeutics, Inc.|YMAB - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham Y-mAbs Therapeutics|YMAB - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ymabs.com|YMAB - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Y-mAbs Therapeutics|YMAB - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Y-mAbs Corp|YMAB - Gunggung utang perusahaan|Utang-utang marang nilai buku Y-mAbs Therapeutics, Inc.|YMAB - Kewajiban jangka dawa perusahaan|Tanggungan jangka cendhak Y-mAbs Therapeutics|Indikator likuiditas cepet ymabs.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
YMAB - Bathi resik|Proyeksi bathi mangsa ngarep Y-mAbs Therapeutics|YMAB - Pangali P/E|Rega marang bathi mangsa ngarep Y-mAbs Therapeutics Inc|YMAB - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Y-mAbs Therapeutics, Inc.|YMAB - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Y-mAbs Therapeutics|YMAB - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ymabs.com|YMAB - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Y-mAbs Therapeutics
Analisis umum perusahaan:YMAB (ymabs.com)
Barang unggulan Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics (YMAB) aims for dominance in the pediatric oncology segment through the commercialization of Danyelza. Analyzing the company's P/E chart, an investor sees the ratio of the asset's market value to its net income. This metric determines the theoretical payback period by measuring the cost of every dollar of earned capital. However, ignoring debt growth while scaling the distribution network could create a risk of capital being frozen in an illiquid asset.

Perusahaan pesaing

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (Ascentage)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis (PSNL) - Rasio rega marang bathi|Erasca Inc - Nilai perusahaan marang bathi resik|DCTH (Delcath) - Pangali P/E|Kapitalisasi marang bathi Aura Corp AURA|Koefisien rega marang bathi CADL (Candel Therapeutics)|ARAY - Kapitalisasi marang bathi|SELLAS Life Sciences Group - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi resik Actuate Therapeutics Inc.|CTOR - Rasio rega marang bathi|TuHURA Biosciences, Inc. (HURA) - Koefisien rega marang bathi|TARA: Pangali P/E|fatetherapeutics.com (FATE) - Pangali P/E|WHWK (Aadi Bioscience, Inc.) - Pangali P/E|Rasio rega marang bathi TCRX|Rasio rega marang bathi Champions Oncology (CSBR)|Periode bali modal bisnis xbiotech.com|CEL-SCI - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OSTX|RADX: Koefisien rega marang bathi|Artiva Biotherapeutics, Inc. - Rasio rega pasar marang bathi resik|ANL: Pangali P/E|Veru Corporation - Nilai perusahaan marang bathi resik|TPST (Tempest Therapeutics) - Pangali P/E|Kapitalisasi marang bathi Xilio XLO|Rasio rega marang bathi Renovaro Inc. (RENB)|MURA (muraloncology.com) - Nilai perusahaan marang bathi resik|Pangali P/E KAPA (Kairos Pharma)|Pangali P/E OnKure Therapeutics, Inc. OKUR|GDTC - Rasio rega marang bathi|Kapitalisasi marang bathi resik CRIS|APLM: Pangali P/E|Kapitalisasi marang bathi Tharimmune Inc (THAR)|Koefisien rega marang bathi ADVB|Pangali P/E Genprex Inc|Koefisien rega marang bathi CLDI (Calidi Biotherapeutics)|Rasio rega pasar marang bathi resik SBFM|Pangali P/E XBIO (Xenetic Biosciences, Inc.)|Periode bali modal bisnis Salarius Pharmaceuticals Inc (SLRX)|Purple Biotech Corp - Pangali P/E|American Oncology Network (AONC) - Koefisien rega marang bathi|BeiGene, Ltd. (BGNE) - Rasio rega marang bathi|CKPT - Periode bali modal bisnis|Koefisien rega marang bathi ELEV|Kapitalisasi marang bathi iCAD Corp ICAD|Rasio rega marang bathi Ikena Oncology, Inc. (IKNA)|Koefisien rega marang bathi Notable Labs Corp NTBL|Pangali P/E VIRX (Viracta Therapeutics, Inc.)|Pangali P/E morphosys.com MOR|NAYA Biosciences Inc. - Pangali P/E|AAPGV: Rasio rega marang bathi